Journal Article
. 2000 Oct; 18(20):3558-85.
doi: 10.1200/JCO.2000.18.20.3558.

2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel

H Ozer 1 J O Armitage  C L Bennett  J Crawford  G D Demetri  P A Pizzo  C A Schiffer  T J Smith  G Somlo  J C Wade  J L Wade  R J Winn  A J Wozniak  M R Somerfield  American Society of Clinical Oncology  
  • PMID: 11032599
  •     105 citations

No abstract available

Management of chemotherapy-induced adverse effects in the treatment of colorectal cancer.
F G Jansman, D T Sleijfer, +2 authors, J R Brouwers.
Drug Saf, 2001 Jun 23; 24(5). PMID: 11419562
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.
J P Sculier, M Paesmans, +13 authors, European Lung Cancer Working Party.
Br J Cancer, 2001 Nov 27; 85(10). PMID: 11720426    Free PMC article.
Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer.
Elliot Newman, Stuart G Marcus, +6 authors, Howard Hochster.
J Gastrointest Surg, 2002 May 07; 6(2). PMID: 11992807
Colony-stimulating factors for the management of neutropenia in cancer patients.
David C Dale.
Drugs, 2002 Dec 14; 62 Suppl 1. PMID: 12479591
Treatment of breast cancer with chemotherapy in combination with filgrastim: approaches to improving therapeutic outcome.
Giuseppe Frasci.
Drugs, 2002 Dec 14; 62 Suppl 1. PMID: 12479592
The role of myelopoietic growth factors in managing cancer in the elderly.
Lodovico Balducci, Ignazio Carreca.
Drugs, 2002 Dec 14; 62 Suppl 1. PMID: 12479594
Filgrastim in patients with neutropenia: potential effects on quality of life.
Gary H Lyman, Nicole M Kuderer.
Drugs, 2002 Dec 14; 62 Suppl 1. PMID: 12479595
Pegfilgrastim administered once per cycle reduces incidence of chemotherapy-induced neutropenia.
Jeffrey Crawford.
Drugs, 2002 Dec 14; 62 Suppl 1. PMID: 12479597
Development and validation of a patient-specific predictive instrument for the need for dose reduction in chemotherapy for breast cancer: a potential decision aid for the use of myeloid growth factors.
Panos Savvides, Norma Terrin, John Erban, Harry P Selker.
Support Care Cancer, 2003 Apr 30; 11(5). PMID: 12720075
Cost analyses of adjunct colony stimulating factors for older patients with acute myeloid leukaemia : can they improve clinical decision making?
Charles L Bennett, Glen T Schumock.
Drugs Aging, 2003 May 17; 20(7). PMID: 12749746
Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study.
H E Innes, D B Smith, +3 authors, E Marshall.
Br J Cancer, 2003 Jul 03; 89(1). PMID: 12838298    Free PMC article.
Drug-induced myelosuppression : diagnosis and management.
Peter J Carey.
Drug Saf, 2003 Jul 17; 26(10). PMID: 12862504
Treatment concepts for elderly patients with acute myeloid leukemia.
Wolfgang R Sperr, Alexander W Hauswirth, +3 authors, Peter Valent.
Wien Klin Wochenschr, 2003 Sep 19; 115(13-14). PMID: 13677269
Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS).
Peter Valent, Friedrich Wimazal, +2 authors, Klaus Geissler.
Wien Klin Wochenschr, 2003 Sep 19; 115(13-14). PMID: 13677270
The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.
Der-Cherng Liang.
Paediatr Drugs, 2003 Sep 27; 5(10). PMID: 14510625
Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer.
G D'Agostino, G Ferrandina, +6 authors, G Scambia.
Br J Cancer, 2003 Oct 02; 89(7). PMID: 14520442    Free PMC article.
Impact of neutropenia on delivering planned adjuvant chemotherapy: UK audit of primary breast cancer patients.
R C F Leonard, D Miles, +2 authors, UK Breast Cancer Neutropenia Audit Group.
Br J Cancer, 2003 Dec 04; 89(11). PMID: 14647139    Free PMC article.
The taxanes: toxicity and quality of life considerations in advanced ovarian cancer.
J P Guastalla, V Diéras.
Br J Cancer, 2003 Dec 09; 89 Suppl 3. PMID: 14661042    Free PMC article.
Actual body weight for determining doses of chemotherapy in obese cancer patients: evaluation of treatment tolerability.
Roksolyana Abdah-Bortnyak, Medy Tsalic, Nissim Haim.
Med Oncol, 2004 Jan 13; 20(4). PMID: 14716032
Economic evaluations of granulocyte colony-stimulating factor: in the prevention and treatment of chemotherapy-induced neutropenia.
Marc Esser, Helmut Brunner.
Pharmacoeconomics, 2004 Jan 31; 21(18). PMID: 14750898
Systematic Review.
Medical visits for chemotherapy and chemotherapy-induced neutropenia: a survey of the impact on patient time and activities.
Barry V Fortner, Kurt Tauer, +4 authors, Lee Schwartzberg.
BMC Cancer, 2004 May 22; 4. PMID: 15153249    Free PMC article.
A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia.
Y Lalami, M Paesmans, +5 authors, J Klastersky.
Support Care Cancer, 2004 Jul 06; 12(10). PMID: 15235901
Use of re-randomized data in meta-analysis.
Iztok Hozo, Benjamin Djulbegovic, Otavio Clark, Gary H Lyman.
BMC Med Res Methodol, 2005 May 11; 5. PMID: 15882470    Free PMC article.
[New medications for treatment of systemic mycoses].
I Schedel.
Internist (Berl), 2005 May 11; 46(6). PMID: 15883795
BBR 3438, a novel 9-aza-anthrapyrazole, in patients with advanced gastric cancer: a phase II study group trial of the Central European Society of Anticancer-Drug Research (CESAR).
R-D Hofheinz, C Porta, +8 authors, A Hochhaus.
Invest New Drugs, 2005 Jul 14; 23(4). PMID: 16012796
Phase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer.
Se Hoon Park, Soo-Mee Bang, +4 authors, Min Chung.
BMC Cancer, 2005 Jul 27; 5. PMID: 16042786    Free PMC article.
Change in cycle 1 to cycle 2 haematological counts predicts toxicity in older patients with breast cancer receiving adjuvant chemotherapy.
Arti Hurria, Kelly Brogan, +6 authors, Clifford Hudis.
Drugs Aging, 2005 Aug 03; 22(8). PMID: 16060720
Granulocyte colony--stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer : the 40% rule revisited.
Elizabeth A Calhoun, Glen T Schumock, +6 authors, Charles L Bennett.
Pharmacoeconomics, 2005 Aug 16; 23(8). PMID: 16097839
The safety of full-dose chemotherapy with secondary prophylactic granulocyte colony stimulating factor (G-CSF) following a prior cycle with febrile neutropenia.
Nissim Haim, Katerina Shulman, Hadassah Goldberg, Medy Tsalic.
Med Oncol, 2005 Aug 20; 22(3). PMID: 16110133
Temporal and geographic variation in the use of hematopoietic growth factors in older women receiving breast cancer chemotherapy: findings from a large population-based cohort.
Xianglin L Du, David R Lairson, Charles E Begley, Shenying Fang.
J Clin Oncol, 2005 Nov 30; 23(34). PMID: 16314624    Free PMC article.
Clinical pharmacokinetics of docetaxel : recent developments.
Sharyn D Baker, Alex Sparreboom, Jaap Verweij.
Clin Pharmacokinet, 2006 Mar 03; 45(3). PMID: 16509758
Phase I-II study of biweekly paclitaxel administration with fixed-dose-rate cisplatin in advanced gastric cancer.
Kensei Yamaguchi, Tomotaka Shimamura, +9 authors, East Japan Gastric Cancer Study Group.
Gastric Cancer, 2006 Mar 25; 9(1). PMID: 16557435
Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer.
S Kümmel, J Krocker, +5 authors, D Elling.
Br J Cancer, 2006 Apr 20; 94(9). PMID: 16622463    Free PMC article.
Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatment.
Matthias Schwenkglenks, Christian Jackisch, +7 authors, Robert Leonard.
Support Care Cancer, 2006 Apr 20; 14(9). PMID: 16622653
Advanced colon cancer: antiprogressive immunotherapy using an autologous hemoderivative.
Eduardo Lasalvia-Prisco, Emilio Garcia-Giralt, +4 authors, Joshemaria Larrañga.
Med Oncol, 2006 Apr 29; 23(1). PMID: 16645234
Necrotizing enterocolitis in neutropenia and chemotherapy: a clinical update and old lessons relearned.
CelesteAnn T Bremer, Brian P Monahan.
Curr Gastroenterol Rep, 2006 Jul 14; 8(4). PMID: 16836946
Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients.
P Quittet, P Ceballos, +11 authors, J F Rossi.
Bone Marrow Transplant, 2006 Aug 03; 38(4). PMID: 16883311    Free PMC article.
Neutropenic enterocolitis.
Marta L Davila.
Curr Treat Options Gastroenterol, 2006 Aug 12; 9(3). PMID: 16901388
Colony-stimulating factors: clinical evidence for treatment and prophylaxis of chemotherapy-induced febrile neutropenia.
César Gómez Raposo, Alvaro Pinto Marín, Manuel González Barón.
Clin Transl Oncol, 2006 Nov 01; 8(10). PMID: 17074671
The war on cancer: a report from the front lines.
Gavin Melmed.
Proc (Bayl Univ Med Cent), 2006 Nov 16; 19(4). PMID: 17106493    Free PMC article.
Prevention of chemotherapy-induced neutropenia by special honey intake.
Jamal Zidan, Lika Shetver, +4 authors, Eitan Friedman.
Med Oncol, 2007 Feb 17; 23(4). PMID: 17303914
Neutropenic enterocolitis: current issues in diagnosis and management.
Marta L Davila.
Curr Infect Dis Rep, 2007 Feb 28; 9(2). PMID: 17324348
Therapeutic use of granulocyte colony-stimulating factors for established febrile neutropenia: effect on costs from a hospital perspective.
Leon E Cosler, Adi Eldar-Lissai, +4 authors, Gary H Lyman.
Pharmacoeconomics, 2007 Apr 04; 25(4). PMID: 17402806
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.
Michael Hallek, Bruce D Cheson, +9 authors, International Workshop on Chronic Lymphocytic Leukemia.
Blood, 2008 Jan 25; 111(12). PMID: 18216293    Free PMC article.
Highly Cited.
Phase I trial of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with thoracic malignancies.
Thomas E Stinchcombe, Mark A Socinski, +4 authors, E Claire Dees.
J Thorac Oncol, 2008 May 02; 3(5). PMID: 18449006    Free PMC article.
Biological therapy for pediatric malignancy: current perspectives.
Bharat Agarwal.
Indian J Pediatr, 2008 Sep 05; 75(8). PMID: 18769896
Treatment of a population based sample of men diagnosed with testicular cancer in the United States.
Michael Osswald, Linda C Harlan, +2 authors, Limin X Clegg.
Urol Oncol, 2008 Sep 19; 27(6). PMID: 18799329    Free PMC article.
A randomised pilot Phase II study of doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC) given 2 weekly with pegfilgrastim (accelerated) vs 3 weekly (standard) for women with early breast cancer.
R L Jones, G Walsh, +5 authors, I E Smith.
Br J Cancer, 2009 Jan 24; 100(2). PMID: 19165198    Free PMC article.
Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma.
Christine Chen, Donna E Reece, +15 authors, Vincent Rajkumar.
Br J Haematol, 2009 Jun 24; 146(2). PMID: 19545290    Free PMC article.
Effect of adiponectin deficiency on intestinal damage and hematopoietic responses of mice exposed to gamma radiation.
Venkatesh Ponemone, Raja Fayad, +2 authors, Giamila Fantuzzi.
Mutat Res, 2009 Jul 09; 690(1-2). PMID: 19583972    Free PMC article.
Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma care.
Ruth Pettengell, Matti Aapro, +5 authors, Jan Walewski.
Clin Drug Investig, 2009 Jul 14; 29(8). PMID: 19591512
Prophylactic G-CSF in patients with early-stage breast cancer: a health economic review.
P Trueman.
Br J Cancer, 2009 Sep 17; 101 Suppl 1. PMID: 19756001    Free PMC article.
Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors.
S Kelly, D Wheatley.
Br J Cancer, 2009 Sep 17; 101 Suppl 1. PMID: 19756005    Free PMC article.
Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia.
Andrew Y Koh, Gregory P Priebe, +2 authors, Gerald B Pier.
Infect Immun, 2009 Oct 07; 77(12). PMID: 19805527    Free PMC article.
Phase II study of biweekly plitidepsin as second-line therapy for advanced or metastatic transitional cell carcinoma of the urothelium.
Herlinde Dumez, Enrique Gallardo, +6 authors, Aude Fléchon.
Mar Drugs, 2009 Oct 21; 7(3). PMID: 19841725    Free PMC article.
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes.
S Pecorelli, I Ray-Coquard, +14 authors, J P Guastalla.
Ann Oncol, 2009 Nov 13; 21(4). PMID: 19906760    Free PMC article.
Supportive care for patients with early breast cancer.
Laura García-Estévez, Ignasi Tusquets, +5 authors, Ana Lluch.
Clin Transl Oncol, 2010 Jan 19; 12(1). PMID: 20080469
Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?
Matti Aapro, Jeffrey Crawford, Didier Kamioner.
Support Care Cancer, 2010 Mar 02; 18(5). PMID: 20191292    Free PMC article.
Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial.
G P Stathopoulos, D Antoniou, +12 authors, G Tsoukalas.
Ann Oncol, 2010 May 05; 21(11). PMID: 20439345    Free PMC article.
Phase I study of weekly plitidepsin as 1-hour infusion combined with carboplatin in patients with advanced solid tumors or lymphomas.
Ramón Salazar, Ruth Plummer, +6 authors, Alan Hilary Calvert.
Invest New Drugs, 2010 Jul 14; 29(6). PMID: 20623160
Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia.
Todd L Rosenblat, Michael R McDevitt, +10 authors, Joseph G Jurcic.
Clin Cancer Res, 2010 Sep 23; 16(21). PMID: 20858843    Free PMC article.
Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumors.
Laura Vidal, Margarita Magem, +8 authors, Ramón Salazar.
Invest New Drugs, 2010 Oct 12; 30(2). PMID: 20927639
Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group.
Minoru Yoshida, Nobu Akiyama, +14 authors, Tomoki Naoe.
Int J Hematol, 2011 Jan 08; 93(1). PMID: 21213127
Phase I combination study of trabectedin and capecitabine in patients with advanced malignancies.
Lia Gore, E Rivera, +8 authors, S G Eckhardt.
Invest New Drugs, 2011 Sep 21; 30(5). PMID: 21931969
A way forward on the medically appropriate use of white cell growth factors.
Thomas J Smith, Bruce E Hillner.
J Clin Oncol, 2012 Mar 01; 30(14). PMID: 22370327    Free PMC article.
Hematopoietic growth factors: personalization of risks and benefits.
Shannon Puhalla, Saveri Bhattacharya, Nancy E Davidson.
Mol Oncol, 2012 Apr 14; 6(2). PMID: 22497867    Free PMC article.
Pharmacoeconomics of the myeloid growth factors: a critical and systematic review.
Bradford R Hirsch, Gary H Lyman.
Pharmacoeconomics, 2012 May 01; 30(6). PMID: 22540394
Systematic Review.
Uncaria tomentosa-Adjuvant Treatment for Breast Cancer: Clinical Trial.
Maria do Carmo Santos Araújo, Iria Luiza Farias, +7 authors, Maria Rosa Chitolina Schetinger.
Evid Based Complement Alternat Med, 2012 Jul 20; 2012. PMID: 22811748    Free PMC article.
Guideline-Based Peer-to-Peer Consultation Optimizes Pegfilgrastim Use With No Adverse Clinical Consequences.
Marc L Fishman, Akhil Kumar, +2 authors, William J M Hrushesky.
J Oncol Pract, 2012 Sep 04; 8(3 Suppl). PMID: 22942828    Free PMC article.
Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206.
Michael J Kelley, Jeffrey A Bogart, +5 authors, Everett E Vokes.
J Thorac Oncol, 2012 Dec 01; 8(1). PMID: 23196276    Free PMC article.
Phase I study of oxaliplatin in combination with gemcitabine, irinotecan, and 5-fluorouracil/leucovorin (G-FLIE) in patients with metastatic solid tumors including adenocarcinoma of the pancreas.
Adam J Olszewski, Michael L Grossbard, +4 authors, Peter S Kozuch.
J Gastrointest Cancer, 2012 Dec 05; 44(2). PMID: 23208490
Effects of spleen status on early outcomes after hematopoietic cell transplantation.
G Akpek, M C Pasquini, +15 authors, V T Ho.
Bone Marrow Transplant, 2012 Dec 12; 48(6). PMID: 23222382    Free PMC article.
Risk factors for febrile neutropenia during chemotherapy for HIV-related lymphoma.
Jinyong Park, Tae Min Kim, +9 authors, Myoung-don Oh.
J Korean Med Sci, 2012 Dec 21; 27(12). PMID: 23255844    Free PMC article.
Randomized double blind trial of ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia.
Pudjo H Widjajanto, Sumadiono Sumadiono, +3 authors, Anjo Jp Veerman.
J Blood Med, 2013 Feb 14; 4. PMID: 23403504    Free PMC article.
Deviations from guideline-based therapy for febrile neutropenia in cancer patients and their effect on outcomes.
Jason D Wright, Alfred I Neugut, +5 authors, Dawn L Hershman.
JAMA Intern Med, 2013 Mar 06; 173(7). PMID: 23460379    Free PMC article.
The association between COX-2 polymorphisms and hematologic toxicity in patients with advanced non-small-cell lung cancer treated with platinum-based chemotherapy.
Fei Zhou, Guanghui Gao, +3 authors, Caicun Zhou.
PLoS One, 2013 Apr 27; 8(4). PMID: 23620771    Free PMC article.
A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance).
Pankaj Gupta, Flora Mulkey, +9 authors, Alliance for Clinical Trials in Oncology.
Invest New Drugs, 2013 May 24; 31(5). PMID: 23700288    Free PMC article.
Risk factors for hematological toxicity of chemotherapy for bone and soft tissue sarcoma.
Zhengxiao Ouyang, Dan Peng, Dibya Purush Dhakal.
Oncol Lett, 2013 Jun 14; 5(5). PMID: 23760066    Free PMC article.
Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy.
Guo-Shiou Liao, Maria Karmella Apaya, Lie-Fen Shyur.
Evid Based Complement Alternat Med, 2013 Jul 11; 2013. PMID: 23840256    Free PMC article.
PointBreak: a randomized phase III study of pemetrexed plus carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.
Jyoti D Patel, Mark A Socinski, +15 authors, Ramaswamy Govindan.
J Clin Oncol, 2013 Oct 23; 31(34). PMID: 24145346    Free PMC article.
Highly Cited.
A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube.
Thomas J Herzog, Bradley J Monk, +9 authors, Barrett H Childs.
Gynecol Oncol, 2014 Jan 31; 132(3). PMID: 24476788    Free PMC article.
Breast cancer in pregnancy: a literature review.
S Deckers, F Amant.
Facts Views Vis Obgyn, 2009 Jan 01; 1(2). PMID: 25478078    Free PMC article.
XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer.
J J Morton, G Bird, +20 authors, A Jimeno.
Oncogene, 2015 Apr 22; 35(3). PMID: 25893296    Free PMC article.
Colony-stimulating factors for chemotherapy-related febrile neutropenia are associated with improved prognosis in adult acute lymphoblastic leukemia.
Shi-Guang Ye, Y I Ding, +3 authors, Ai-Bin Liang.
Mol Clin Oncol, 2015 Jul 15; 3(3). PMID: 26161258    Free PMC article.
G-CSF and GM-CSF in Neutropenia.
Hrishikesh M Mehta, Michael Malandra, Seth J Corey.
J Immunol, 2015 Aug 09; 195(4). PMID: 26254266    Free PMC article.
A Phase III Study of Balugrastim Versus Pegfilgrastim in Breast Cancer Patients Receiving Chemotherapy With Doxorubicin and Docetaxel.
Oleg Gladkov, Vladimir Moiseyenko, +4 authors, Noa Avisar.
Oncologist, 2015 Dec 17; 21(1). PMID: 26668251    Free PMC article.
Molecular Pathways: Targeting Cancer Stem Cells Awakened by Chemotherapy to Abrogate Tumor Repopulation.
Keith Syson Chan.
Clin Cancer Res, 2015 Dec 17; 22(4). PMID: 26671994    Free PMC article.
Pharmacoeconomic effect of compliance with pharmacist's intervention based on cancer chemotherapy regimens: a cohort study.
Makoto Hayashi, Akimasa Yamatani, Hiromu Funaki, Kenichi Miyamoto.
J Pharm Health Care Sci, 2016 Jan 29; 1. PMID: 26819721    Free PMC article.
The Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC).
Ji Yun Lee, Sung Hee Lim, +4 authors, Yeon Hee Park.
PLoS One, 2016 Feb 24; 11(2). PMID: 26901062    Free PMC article.
Biosimilars in the management of neutropenia: focus on filgrastim.
Désirée Caselli, Simone Cesaro, Maurizio Aricò.
Biologics, 2016 Mar 05; 10. PMID: 26937170    Free PMC article.
Chemotherapy-induced neutropenia among pediatric cancer patients in Egypt: Risks and consequences.
Mohamed Badr, Tamer Hassan, +5 authors, Sahbaa Fehr.
Mol Clin Oncol, 2016 Sep 03; 5(3). PMID: 27588196    Free PMC article.
On the origin of myeloid-derived suppressor cells.
Camilla Rydberg Millrud, Caroline Bergenfelz, Karin Leandersson.
Oncotarget, 2016 Oct 01; 8(2). PMID: 27690299    Free PMC article.
Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494).
Vicki A Morrison, Edie A Weller, +4 authors, Bruce A Peterson.
Leuk Lymphoma, 2016 Dec 15; 58(8). PMID: 27967294    Free PMC article.
Saponins from Sanguisorba officinalis Improve Hematopoiesis by Promoting Survival through FAK and Erk1/2 Activation and Modulating Cytokine Production in Bone Marrow.
Xin Chen, Bogang Li, +3 authors, Shuang Chen.
Front Pharmacol, 2017 Apr 01; 8. PMID: 28360858    Free PMC article.
Time trends in utilization of G-CSF prophylaxis and risk of febrile neutropenia in a Medicare population receiving adjuvant chemotherapy for early-stage breast cancer.
Ravi K Goyal, Spiros Tzivelekis, +2 authors, James A Kaye.
Support Care Cancer, 2017 Sep 19; 26(2). PMID: 28921379
A phase I study of different doses and frequencies of pegylated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF) in patients with standard-dose chemotherapy-induced neutropenia.
Yan Qin, Xiaohong Han, +7 authors, Yuankai Shi.
Chin J Cancer Res, 2017 Nov 17; 29(5). PMID: 29142459    Free PMC article.
A multicenter prospective study of 515 febrile neutropenia episodes in Argentina during a 5-year period.
Roberto L Parodi, Mariana Lagrutta, +7 authors, Alcides A Greca.
PLoS One, 2019 Nov 02; 14(10). PMID: 31671108    Free PMC article.
Network Pharmacology-Based Investigation of the System-Level Molecular Mechanisms of the Hematopoietic Activity of Samul-Tang, a Traditional Korean Herbal Formula.
Ho-Sung Lee, In-Hee Lee, Sang-In Park, Dae-Yeon Lee.
Evid Based Complement Alternat Med, 2020 Feb 28; 2020. PMID: 32104198    Free PMC article.
Efficacy of Jackfruit365™ Green Jackfruit Flour Fortified Diet on Pegfilgrastim to Prevent Chemotherapy-Induced Leukopenia, Irrespective of Tumor Type or Drugs Used-A Retrospective Study.
Thomas Varughese, James Joseph, Rejeesh Menon.
Biomolecules, 2020 Feb 07; 10(2). PMID: 32024271    Free PMC article.
Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.
Julia Bohlius, Christine Herbst, +2 authors, Andreas Engert.
Cochrane Database Syst Rev, 2008 Oct 10; (4). PMID: 18843642    Free PMC article.
Systematic Review.
Green-Synthesized Silver Nanoparticles Induced Apoptotic Cell Death in MCF-7 Breast Cancer Cells by Generating Reactive Oxygen Species and Activating Caspase 3 and 9 Enzyme Activities.
Ikram Ullah, Ali Talha Khalil, +4 authors, Zabta Khan Shinwari.
Oxid Med Cell Longev, 2020 Oct 22; 2020. PMID: 33082906    Free PMC article.
[Pharmacokinetics and pharmacodynamics of pegylated recombinant human granulocyte colony-stimulating factor in children with acute lymphoblastic leukemia: a prospective control trial].
Wen-Yu Yang, Tian-Feng Liu, +11 authors, Xiao-Fan Zhu.
Zhongguo Dang Dai Er Ke Za Zhi, 2020 Nov 12; 22(11). PMID: 33172550    Free PMC article.
Filgrastim-Associated Pneumonitis in Cancer Patient Undergoing Hematopoietic Stem Cell (HSC) Mobilization for Autologous-HSC Transplantation.
Drashti R Patel, Xavier Fonseca, Ashokakumar M Patel.
Cureus, 2021 Jan 26; 12(12). PMID: 33489529    Free PMC article.
Chemotherapy induced neutropenia and febrile neutropenia among breast cancer patients in a tertiary hospital in Nigeria.
Omolola Salako, Kehinde Sharafadeen Okunade, +2 authors, Oluwasegun Joshua Afolaranmi.
Ecancermedicalscience, 2021 Mar 30; 15. PMID: 33777181    Free PMC article.
Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy.
Shanshan Chen, Yiqun Han, +15 authors, Binghe Xu.
BMC Cancer, 2021 Apr 02; 21(1). PMID: 33789616    Free PMC article.